QUANTITATIVE FLOW CYTOMETRIC ANALYSIS OF OPSONOPHAGOCYTOSIS AND KILLING OF NONENCAPSULATED HAEMOPHILUS-INFLUENZAE BY HUMAN POLYMORPHONUCLEAR LEUKOCYTES
L. Vogel et al., QUANTITATIVE FLOW CYTOMETRIC ANALYSIS OF OPSONOPHAGOCYTOSIS AND KILLING OF NONENCAPSULATED HAEMOPHILUS-INFLUENZAE BY HUMAN POLYMORPHONUCLEAR LEUKOCYTES, Clinical and diagnostic laboratory immunology, 1(4), 1994, pp. 394-400
Since nonencapsulated Haemophilus influenzae persists in the lower res
piratory tracts of patients with chronic bronchitis despite the presen
ce of specific antibodies, complement, and polymorphonuclear leukocyte
s (PMNs), opsonophagocytosis of H. influenzae was analyzed. Nonencapsu
lated H. influenzae isolated from the sputa of chronic bronchitis pati
ents was labeled with fluorescein isothiocyanate and incubated, with h
uman PMNs in the presence of complement and antibodies for 30 min at 3
7 degrees C. Candida albicans was added to each sample as an internal
standard, and the reduction of the number of bacteria was determined b
y flow cytometry. Fluorescence quenching with ethidium bromide was use
d to discriminate between intracellular and extracellular bacteria. Op
sonophagocytosis of viable H. influenzae d1 was 17% +/- 29% in the pre
sence of complement and human pooled sera containing high titers of st
rain-specific antibodies. Opsonophagocytosis of six other H. influenza
e strains was also poor. Under the same conditions, opsonophagocytosis
of Staphylococcus aureus was 90% +/- 5%, and opsonophagocytosis of C.
albicans was 55% +/- 23%. About half of the number of H. influenzae b
acteria associated with PMNs was internalized. Opsonophagocytosis of h
eat-killed H. influenzae d1 (41% +/- 20%) was higher than that of viab
le bacteria of the same strain (p < 0.05). This result suggests that t
he accessibility of epitopes on H. influenzae for opsonizing antibodie
s in better on killed than on viable bacteria. We concluded that viabl
e nonencapsulated H. influenzae is poorly opsonophagocytized in the pr
esence of strain-specific antibodies and complement.